Pilot Study of Bisphosphonate Therapy (Zoledronic Acid) in Patients With Malignant Mesothelioma (UAB 0901)
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to determine the response rate of single agent
zoledronic acid using a composite of criteria including the EORTC modified RECIST criteria
and the EORTC tumor response criteria for 18F-FDG PET scans.